Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Creative BioMolecules, Enzon Inc., XOMA Corp. deal

XOMA (Berkeley, Calif.) received worldwide, non-exclusive rights to use

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE